Prevention of central venous catheter-related infection in the intensive care unit

Critical Care

Volumn 14, Issue 2, 2010, Pages

  Frasca, Denis ^a   Dahyot Fizelier, Claire ^a   Mimoz, Olivier ^a  

^a POITIERS UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BENZALKONIUM CHLORIDE; BENZYL ALCOHOL; CHLORHEXIDINE; VANCOMYCIN;

ANTIBIOTIC PROPHYLAXIS; CATHETER INFECTION; CENTRAL VENOUS CATHETER; CLINICAL PROTOCOL; ECHOGRAPHY; EMERGENCY MEDICINE; HEALTH CARE QUALITY; HUMAN; INFECTION PREVENTION; INFECTION RISK; INTENSIVE CARE UNIT; MULTICENTER STUDY (TOPIC); PATHOPHYSIOLOGY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SKIN DECONTAMINATION; STAFF TRAINING; VASCULAR ACCESS; CENTRAL VENOUS CATHETERIZATION; ECONOMICS; STANDARD; UNITED STATES;

CATHETER-RELATED INFECTIONS; CATHETERIZATION, CENTRAL VENOUS; HUMANS; INTENSIVE CARE UNITS; UNITED STATES;

EID: 77958125764     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc8853     Document Type: Review

References (52)

1. Mermel LA. Prevention of intravascular catheter-related infections. Ann Intern Med 2000, 132:391-402.
2. O'Grady NP, Alexander M, Dellinger EP, et al. Guidelines for the prevention of intravascular catheter-related infections. Infect Control Hosp Epidemiol 2002, 23:759-769. 10.1086/502007, 12517020.
3. Herrmann M, Lai QJ, Albrecht RM, Mosher DF. Adhesion of Staphylococcus aureus to surface-bound platelets: role of fibrinogen/fibrin and platelet integrins. J Infect Dis 2003, 167:312-322.
4. Centers for Disease Control and Prevention Issues in healthcare settings: CDC's 7 Healthcare Safety Challenges. Accessed November 26, 2009 , Centers for Disease Control and Prevention., http://www.cdc.gov/ncidod/dhqp/about_challenges.html
5. Berenholtz SM, Pronovost PJ, Lipsett PA, et al. Eliminating catheter-related bloodstream infections in the intensive care unit. Crit Care Med 2004, 32:2014-2020. 10.1097/01.CCM.0000142399.70913.2F, 15483409.
6. Warren DK, Zack JE, Mayfield JL, et al. The effect of an education programme on the incidence of central venous catheter-associated bloodstream infection in a medical ICU. Chest 2004, 126:1612-1618. 10.1378/chest.126.5.1612, 15539735.
7. Eggimann P, Harbarth S, Constantin MN, Touveneau S, Chevrolet JC, Pittet D. Impact of a prevention strategy targeted at vascular-access care on incidence of infections acquired in intensive care. Lancet 2000, 355:1864-1868. 10.1016/S0140-6736(00)02291-1, 10866442.
8. L'Hériteau F, Olivier M, Maugat S. Impact of a five-year surveillance of central venous catheter infections in the REACAT intensive care unit network in France. J Hosp Infect 2007, 66:123-129. 10.1016/j.jhin.2007.03.014, 17517447.
9. Yilmaz G, Koksal I, Aydin K, Caylan R, Sucu N, Aksoy F. Risk factors of catheter-related bloodstream infections in parenteral nutrition catheterization. J Parenter Enteral Nutr 2007, 31:284-287.
10. Zingg W, Imhof A, Maggiorini M, Stocker R, Keller E, Ruef C. Impact of a prevention strategy targeting hand hygiene and catheter care on the incidence of catheter-related bloodstream infections. Crit Care Med 2009, 37:2167-2173. 10.1097/CCM.0b013e3181a02d8f, 19487942.
11. Barsuk JH, Cohen ER, Feinglass J, McGaghie WC, Wayne DB. Use of simulation-based education to reduce catheter-related bloodstream infections. Arch Intern Med 2009, 169:1420-1423. 10.1001/archinternmed.2009.215, 19667306.
12. Soifer NE, Borzak S, Edlin BR, Weinstein RA. Prevention of peripheral venous catheter complications with an intravenous therapy team: a randomized controlled trial. Arch Intern Med 1998, 158:473-477. 10.1001/archinte.158.5.473, 9508225.
13. Puntis JW, Holden CE, Smallman S, Finkel Y, George RH, Booth IW. Staff training: a key factor in reducing intravascular catheter sepsis. Arch Dis Child 1991, 66:335-337. 10.1136/adc.66.3.335, 1792884, 1902650.
14. Fridkin SK, Pear SM, Williamson TH, Galgiani JN, Jarvis WR. The role of understaffing in central venous catheter-associated bloodstream infections. Infect Control Hosp Epidemiol 1993, 17:150-158.
15. Alonso-Echanove J, Edwards JR, Richards MJ, et al. Effect of nurse staffing and antimicrobial-impregnated central venous catheters on the risk for bloodstream infections in intensive care units. Infect Control Hosp Epidemiol 2003, 24:916-925. 10.1086/502160, 14700407.
16. Maki DG, Ringer M. Risk factors for infusion-related phlebitis with small peripheral venous catheters: a randomized controlled trial. Ann Intern Med 1991, 114:845-854.
17. Sheth NK, Franson TR, Rose HD, Buckmire FL, Cooper JA, Sohnle PG. Colonization of bacteria on polyvinyl chloride and Teflon intravascular catheters in hospitalized patients. J Clin Microbiol 1983, 18:1061-1063. 272841, 6643657.
18. Halton KA, Cook DA, Whitby M, Paterson DL, Graves N. Cost effectiveness of antimicrobial catheters in the intensive care unit: addressing uncertainty in the decision. Crit Care 2009, 13:R35. 10.1186/cc7744, 2689469, 19284570.
19. Raad I, Buzaid A, Rhyne J. Minocycline and ethylenediaminetetraacetate for the prevention of recurrent vascular catheter infections. Clin Infect Dis 1997, 25:149-151. 10.1086/514518, 9243049.
20. Ramritu P, Halton K, Collignon P. A systematic review comparing the relative effectiveness of antimicrobial-coated catheters in intensive care units. Am J Infect Control 2008, 36:104-117. 10.1016/j.ajic.2007.02.012, 18313512.
21. Kalfon P, de Vaumas C, Samba D. Comparison of silver-impregnated with standard multi-lumen central venous catheters in critically ill patients. Crit Care Med 2007, 35:1032-1039. 10.1097/01.CCM.0000259378.53166.1B, 17334256.
22. Hockenhull JC, Dwan KM, Smith GW. The clinical effectiveness of central venous catheters treated with anti-infective agents in preventing catheter-related bloodstream infections: a systematic review. Crit Care Med 2009, 37:702-712. 10.1097/CCM.0b013e3181958915, 19114884.
23. Dezfulian C, Lavelle J, Nallamothu BK, Kaufman SR, Saint S. Rates of infection for single-lumen versus multilumen central venous catheters: a meta-analysis. Crit Care Med 2003, 31:2385-2390. 10.1097/01.CCM.0000084843.31852.01, 14501971.
24. Merrer J, De Jonghe B, Golliot F, . French Catheter Study Group in Intensive Care Complications of femoral and subclavian venous catheterization in critically ill patients: a randomized controlled trial. JAMA 2001, 286:700-707. 10.1001/jama.286.6.700, 11495620, French Catheter Study Group in Intensive Care.
25. Ruesch S, Walder B, Tramèr MR. Complications of central venous catheters: internal jugular versus subclavian access - a systematic review. Crit Care Med 2002, 30:454-460. 10.1097/00003246-200202000-00031, 11889329.
26. Parienti JJ, Thirion M, Mégarbane B, et al. Femoral vs jugular venous catheterization and risk of nosocomial events in adults requiring acute renal replacement therapy: a randomized controlled trial. JAMA 2008, 99:2413-2422.
27. Randolph AG, Cook DJ, Gonzales CA, Pribble CG. Ultrasound guidance for placement of central venous catheters: a meta-analysis of the literature. Crit Care Med 1996, 24:2053-2058. 10.1097/00003246-199612000-00020, 8968276.
28. Karakitsos D, Labropoulos N, De Groot E. Real-time ultrasound-guided catheterisation of the internal jugular vein: a prospective comparison with the landmark technique in critical care patients. Crit Care 10:R162. 10.1186/cc5101, 1794469, 17112371.
29. Raad II, Hohn DC, Gilbreath BJ, et al. Prevention of central venous catheter-related infections by using maximal sterile barrier precautions during insertion. Infect Control Hosp Epidemiol 15:231-238. 10.1086/646902, 8207189.
30. Chaiyakunapruk N, Veenstra DL, Lipsky BA, Saint S. Chlorhexidine compared with povidone iodine solution for vascular catheter-site care: a meta-analysis. Ann Intern Med 2002, 136:792-801.
31. Balamongkhon B, Thamlikitkul V. Implementation of chlorhexidine gluconate for central venous catheter site care at Siriraj Hospital, Bangkok, Thailand. Am J Infect Control 2007, 35:585-588. 10.1016/j.ajic.2006.12.002, 17980236.
32. Parienti JJ, du Cheyron D, Ramakers M, et al. Alcoholic povidone-iodine to prevent central venous catheter colonization: a randomized unit-crossover study. Crit Care Med 2004, 32:708-713. 10.1097/01.CCM.0000115265.05604.7B, 15090951.
33. Mimoz O, Villeminey S, Ragot S. Chlorhexidine-based antiseptic solution versus alcohol-based povidone-iodine for central venous catheter care. Arch Intern Med 2007, 167:2066-2072. 10.1001/archinte.167.19.2066, 17954800.
34. Spafford PS, Sinkin RA, Cox C. Prevention of central venous catheter-related coagulase-negative staphylococcal sepsis in neonates. J Pediatr 1994, 125:259-263. 10.1016/S0022-3476(94)70208-X, 8040776.
35. Kacica MA, Horgan MJ, Ochoa L, Sandler R, Lepow ML, Venezia RA. Prevention of gram-positive sepsis in neonates weighing less than 1500 g. J Pediatr 1994, 125:253-258. 10.1016/S0022-3476(94)70207-1, 8040775.
36. Randolph AG, Cook DJ, Gonzales CA, Brun-Buisson C. Tunneling short-term central venous catheters to prevent catheter-related infection: a meta-analysis of randomized, controlled trials. Crit Care Med 1998, 26:1452-1457. 10.1097/00003246-199808000-00038, 9710109.
37. Ho KM, Litton E. Use of chlorhexidine-impregnated dressing to prevent vascular and epidural catheter colonization and infection: a meta-analysis. J Antimicrob Chemother 2006, 58:281-287. 10.1093/jac/dkl234, 16757502.
38. Timsit JF, Schwebel C, Bouadma L, et al. Chlorhexidine-impregnated sponges and less frequent dressing changes for prevention of catheter-related infections in critically ill adults: a randomized controlled trial. JAMA 2009, 301:1231-1241. 10.1001/jama.2009.376, 19318651.
39. Maki DG, Botticelli JT, LeRoy ML, Thielke TS. Prospective study of replacing administration sets for intravenous therapy at 48- vs 72-hour intervals: 72 hours is safe and cost-effective. JAMA 1987, 258:1777-1781. 10.1001/jama.258.13.1777, 3114506.
40. Raad I, Hanna HA, Awad A, et al. Optimal frequency of changing intra-venous administration sets: is it safe to prolong use beyond 72 hours?. Infect Control Hosp Epidemiol 2001, 22:136-139. 10.1086/501879, 11310690.
41. Band JD, Maki DG. Safety of changing intravenous delivery systems at longer than 24-hour intervals. Ann Intern Med 1979, 91:173-178.
42. Gillies D, O'Riordan L, Wallen M, Rankin K, Morrison A, Nagy S. Timing of intravenous administration set changes: a systematic review. Infect Control Hosp Epidemiol 2004, 25:240-250. 10.1086/502385, 15061417.
43. Sitges-Serra A, Linares J, Perez JL, Jaurrieta E, Lorente L. A randomized trial on the effect of tubing changes on hub colonization and catheter sepsis during parenteral nutrition. JPEN J Parenter Enteral Nutr 1985, 9:322-325. 10.1177/0148607185009003322, 3925176.
44. Salzman MB, Isenberg HD, Rubin LG. Use of disinfectants to reduce microbial contamination of hubs of vascular catheters. J Clin Microbiol 1993, 31:475-479. 262804, 8458938.
45. Khalifa R, Dahyot-Fizelier C, Laksiri L. Indwelling time and risk of colonization of peripheral arterial catheters in critically ill patients. Intensive Care Med 2008, 34:1820-1826. 10.1007/s00134-008-1139-z, 18483721.
46. Cobb DK, High KP, Sawyer RG. A controlled trial of scheduled replacement of central venous and pulmonary artery catheter. N Engl J Med 1992, 327:1062-1068.
47. Cook D, Randolph A, Kemerman P, et al. Central venous catheter replacement strategies: A systematic review of the literature. Crit Care Med 1997, 25:1417-1424. 10.1097/00003246-199708000-00033, 9267959.
48. Zakrzewska-Bode A, Muytjens HL, Liem KD, Hoogkamp-Korstanje JA. Mupirocin resistance in coagulase-negative staphylococci, after topical prophylaxis for the reduction of colonization of central venous catheters. J Hosp Infect 1995, 31:189-193. 10.1016/0195-6701(95)90065-9, 8586787.
49. Randolph AG, Cook DJ, Gonzales CA, Andrew M. Benefit of heparin in central venous and pulmonary artery catheters: a meta-analysis of randomized controlled trials. Chest 1998, 113:165-171. 10.1378/chest.113.1.165, 9440585.
50. Pronovost P, Needham D, Berenholtz S. An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl J Med 2006, 355:2725-2732. 10.1056/NEJMoa061115, 17192537.
51. Timsit JF. Diagnosis and prevention of catheter-related infections. Curr Opin Crit Care 2007, 13:563-571. 10.1097/MCC.0b013e3282efa03f, 17762237.
52. Mermel LA, Farr BM, Sherertz RJ, et al. Guidelines for the management of intravascular catheter-related infections. Infect Control Hosp Epidemiol 2001, 22:222-242. 10.1086/501893, 11379714.